Telix opens Australian-first radiopharmaceutical facility
July 16, 2026 | 11:13
Telix Pharmaceuticals, dual-listed on ASX and Nasdaq, officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, expanding Australia's sovereign cancer treatment manufacturing capacity.
Mobile Version